Antioxidant Therapy Tested in Early Parkinson’s

(MedPage Today) -- Treatment with the urate precursor inosine did not result in a significant difference in the rate of clinical disease progression in early Parkinson's disease, the phase III SURE-PD3 trial showed.
Clinical progression rates...